Nordea underwrites Pronova loan

05 Oct 2010

Norwegian pharmaceutical firm Pronova BioPharm is syndicating a Nkr2.38bn (Eu296m, $407m) five year loan that Nordea has underwritten.

The facility, which is split into a Nkr1.78bn multi-currency term loan and a Nkr500m multicurrency revolver, is being marketed to a small group of banks, including new lenders. Syndication is expected to close at the end of the month.

The term loan is split into a Nkr680m tranche ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Oops, something went wrong

We're sorry but at the moment we can't load this data